@prefix cas: <http://identifiers.org/cas/> .
@prefix chemspider: <http://identifiers.org/chemspider/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix pubchem: <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-UFZ-WANA058113D9F1PH a mbo:MassSpectrum ;
    dcterms:creator "Tobias Schulze, Martin Krauss, Department of Effect-Directed Analysis, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany" ;
    dcterms:date "2023-08-12"^^xsd:date ;
    dcterms:identifier "MSBNK-UFZ-WANA058113D9F1PH" ;
    dcterms:license <https://creativecommons.org/publicdomain/zero/1.0/> ;
    dcterms:rights "Copyright (C) 2023 under CC0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "LTQ Orbitrap XL Thermo Scientific" ;
            mbo:collision_energy "50 % (nominal)" ;
            mbo:column_name "Kinetex Evo C18 2.6 um 50 x 2.1 mm" ;
            mbo:flow_gradient "95/5 at 0 min, 95/5 at 1 min, 0/100 at 13 min, 0/100 at 24 min, 95/5 at 24.3 min, 95/5 at 32 min" ;
            mbo:flow_rate "300 uL/min" ;
            mbo:fragmentation_mode "HCD" ;
            mbo:instrument_type "LC-ESI-ITFT" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:resolution "15000" ;
            mbo:retention_time "10.313 min" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one",
                "Lorazepam" ;
            mbo:ch_compound_class "N/A; Environmental Standard" ;
            mbo:ch_exact_mass 3.200119e+02 ;
            rdfs:seeAlso cas:846-49-1,
                chemspider:3821,
                pubchem:CID3958 ;
            schema:inChI "InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)" ;
            schema:inChIKey inchikey:DIWRORZWFLOCLC-UHFFFAOYSA-N ;
            schema:molecularFormula "C15H10Cl2N2O2" ;
            schema:name "7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one",
                "Lorazepam" ;
            schema:smiles "OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2" ] ;
    mbo:has_peak [ mbo:intensity 2.964e+03 ;
            mbo:mz 9.30574e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 2.3107e+03 ;
            mbo:mz 2.390371e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 5 ],
        [ mbo:intensity 4.9421e+03 ;
            mbo:mz 2.500189e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 3.4674e+03 ;
            mbo:mz 2.570483e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 7 ],
        [ mbo:intensity 3.86754e+04 ;
            mbo:mz 2.650297e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 81 ],
        [ mbo:intensity 4.78823e+05 ;
            mbo:mz 2.750141e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 2.1518e+03 ;
            mbo:mz 2.759977e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 3.9401e+03 ;
            mbo:mz 2.910083e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 2.0596e+03 ;
            mbo:mz 2.920167e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 4.66359e+04 ;
            mbo:mz 3.03009e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 97 ],
        [ mbo:intensity 1.447e+03 ;
            mbo:mz 3.21018e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 2.44272e+04 ;
            mbo:mz 1.280263e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 51 ],
        [ mbo:intensity 4.0648e+04 ;
            mbo:mz 1.380106e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 85 ],
        [ mbo:intensity 5.13e+03 ;
            mbo:mz 1.530216e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 3.6004e+03 ;
            mbo:mz 1.560212e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 8 ],
        [ mbo:intensity 1.8478e+04 ;
            mbo:mz 1.630059e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 39 ],
        [ mbo:intensity 8.1281e+03 ;
            mbo:mz 1.660056e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 17 ],
        [ mbo:intensity 1.7073e+03 ;
            mbo:mz 2.140421e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 2.492926e+05 ;
            mbo:mz 2.29053e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 520 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:base_peak 5.152449e+02 ;
            mbo:precursor_mz 3.210192e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 19 ;
    mbo:pk_splash "splash10-004i-0190000000-1838f702a7bc3773afe9" ;
    rdfs:comment "CONFIDENCE Reference Standard (Level 1)" ;
    skos:definition "Lorazepam; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+" .

